Premium Reports
Small Practice Ambulatory EMR/PM (10 or Fewer Physicians) 2019

Small Practice Ambulatory EMR/PM (10 or Fewer Physicians) 2019
Building Strong Foundations for Customer Success

Authored by: Aaron Gleave and Alex McIntosh February 5, 2019 | Read Time: 3  minutes

As healthcare has moved beyond meaningful use, small practices have begun to expect more from their vendors and to look for EMRs that do morethan meet basic regulatory requirements. As a result, EMR/PM satisfaction among small practices (10 or fewer physicians) has varied greatly over thepast year—scores for a number of vendors have swung more than 10 percentage points (some positively, some negatively). To explore what the futureholds for this market, KLAS spoke to hundreds of small practice customers about their EMR/PM experiences and needs and also interviewed executivesand representatives from AdvancedMD, Allscripts, Aprima, athenahealth, Azalea Health, CareCloud, Cerner, CureMD, eMDs, Greenway Health, Kareo,NextGen, Quest Diagnostics, and Virence Health (GE Healthcare) to find out how these vendors plan to increase customer satisfaction going forward.

Healthcare Providers,
Want to see full details?

Not a Provider, contact us for pricing details.

Key Findings

  1. NextGen Healthcare, CureMD, and Aprima Most Aligned to Deliver Customer Success
  2. Practices Want CareCloud, Cerner, and eMDs to Focus on the Basics
  3. AdvancedMD and Greenway Health Quickly Becoming Top-Performing Contenders
  4. Virence Health and Cerner See Significant Declines
  5. More Investment in Training Needed for Better Provider Success
 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2020 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.